Cytokine activation induces human memory-like NK cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-12-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2012-04-419283PMID 22983442PMCID PMC3520618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-Deficient NK Cells Exhibit Decreased Survival but Enhanced Function

  2012cited by this paper
• Proinflammatory cytokine signaling required for the generation of natural killer cell memory

  2012cited by this paper
• Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

  2012cited by this paper
• Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.

  2012cited by this paper
• Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

  2011cited by this paper
• Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

  2011cited by this paper
• The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

  2011cited by this paper
• Unconventional Repertoire Profile Is Imprinted during Acute Chikungunya Infection for Natural Killer Cells Polarization toward Cytotoxicity

  2011cited by this paper
• CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.

  2010cited by this paper
• Latent herpesvirus infection arms NK cells.

  2010cited by this paper
• CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

  2010cited by this paper
• Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses

  2010cited by this paper
• Critical role for the chemokine receptor CXCR 6 in NK cell – mediated antigen-specific memory of haptens and viruses

  2010cited by this paper
• Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice

  2010cited by this paper
• NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs

  2010cited by this paper
• Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

  2010cited by this paper
• Chapter 2 Natural Killer Cell Tolerance

  2009cited by this paper
• Adaptive Immune Features of Natural Killer Cells

  2009cited by this paper
• Hidden talents of natural killers: NK cells in innate and adaptive immunity

  2009cited by this paper
• Cytokine-induced memory-like natural killer cells

  2009cited by this paper
• Natural killer cell tolerance licensing and other mechanisms.

  2009cited by this paper
• Natural killer cells: diversity in search of a niche

  2008cited by this paper
• Evolutionary struggles between NK cells and viruses

  2008cited by this paper
• Human natural killer cells.

  2008cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Prospects for the use of NK cells in immunotherapy of human cancer

  2007cited by this paper
• Human natural killer cell development

  2006cited by this paper
• T cell– and B cell–independent adaptive immunity mediated by natural killer cells

  2006cited by this paper
• Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

  2006cited by this paper
• Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

  2005cited by this paper
• Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

  2004cited by this paper
• CD107a as a functional marker for the identification of natural killer cell activity.

  2004cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• Regulation of interferon-gamma gene expression.

  1996cited by this paper
• Regulation of Interferon-γ Gene Expression

  1996cited by this paper
• Human natural killer cells.

  1979cited by this paper

• Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants

  2026cites this paper
• Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models.

  2026cites this paper
• Bibliometric and Visual Analysis of Trained Immunity from 2005 to 2024

  2026cites this paper
• Post-translational modification of NK cell receptors offers clues to antigenic specificity riddle

  2026cites this paper
• Current development and challenges of NK cell-based immunotherapy for gastrointestinal cancers.

  2026cites this paper
• Bromodomain and extra-terminal protein inhibitors modulate natural killer cell function and differentiation

  2026cites this paper
• Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges

  2026cites this paper
• From innate-like to innate: the next wave of off-the-shelf CAR immunotherapies

  2026cites this paper
• Bringing natural killer cells to the clinic: Opportunities beyond cancer.

  2026cites this paper
• Synergistic immune interactions between T cells and natural killer cells in allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: current status and future directions

  2026cites this paper
• A Novel Natural Killer Cell Expansion Technology for the Development of Cellular Immunotherapies

  2026cites this paper
• Chimeric Antigen Receptor-Engineered Natural Killer (CAR-NK) Cell Therapy in Acute Myeloid Leukemia: A Systematic Review of the Literature

  2025cites this paper
• Engineered natural killer cells for cancer therapy.

  2025cites this paper
• The landscape of CAR-engineered innate immune cells for cancer immunotherapy

  2025cites this paper
• Engineering innate immune cells for cancer immunotherapy

  2025cites this paper
• Ly49G, but not Ly49C/I, is dispensable for diverse antigen-specific memory NK cell responses in H-2d and H-2b mice

  2025cites this paper
• Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia

  2025cites this paper
• NK-derived exosomes in anti-tumor strategies

  2025cites this paper
• Species-specific serine metabolism differentially controls natural killer cell functions

  2025cites this paper
• Advances in cancer immunotherapy: The role of super NK and super CAR-T cells.

  2025cites this paper
• SEMA7A: A glycoprotein with therapeutic potential in inflammatory diseases and tumor development.

  2025cites this paper
• The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies.

  2025cites this paper
• Phenotypic and epigenetic profiles of circulating NK cells in spontaneous HIV-1 controllers

  2025cites this paper
• Nanomaterial-Interleukin Combination for Boosting NK Cell-Based Tumor Immunotherapy.

  2025cites this paper
• A systematic review of the last two decades of NK cell-based clinical trials: state of the art of AML therapy

  2025cites this paper
• Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy

  2025cites this paper
• Therapeutic Salmonella induces long-term protective trained immunity in NK cells against cancer metastasis

  2025cites this paper
• Novel tetrameric bispecific KK-LC-1×CD16A-armed memory-like NK cells enhance antitumor efficacy in gastric cancer

  2025cites this paper
• Self-lytic Nano-bacterial biohybrid reprograms Intratumoral microbiome-immune interactions for cancer immunotherapy.

  2025cites this paper
• Harnessing lipid metabolism through diacylglycerol kinases: implications for immune modulation and cancer therapy.

  2025cites this paper
• Trained immunity in the lung

  2025cites this paper
• A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodies.

  2025cites this paper
• Metabolic dysregulation of trained immunity in immune aging and the impact of dietary patterns.

  2025cites this paper
• Splenic TNF-α signaling potentiates the innate-to-adaptive transition of antiviral NK cells.

  2025cites this paper
• CAR-NK cell therapy: a potential antiviral platform.

  2025cites this paper
• Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies

  2025cites this paper
• Advances in the role of NK cells in MDS immune dysfunction and antitumor research

  2025cites this paper
• CD56bright cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells

  2025cites this paper
• Exercise-mobilized donor lymphocyte infusions enhanced with cytokine stimulation for the prevention and treatment of leukemic relapse after allogeneic hematopoietic cell transplantation

  2025cites this paper
• NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity.

  2025cites this paper
• Senescence, NK cells, and cancer: navigating the crossroads of aging and disease

  2025cites this paper
• Tumor hypoxia shapes natural killer cell anticancer activities

  2025cites this paper
• NK cells undergo transcriptional and functional reprogramming following Streptococcus pneumoniae infection

  2025cites this paper
• A rapid ex vivo co-culture of memory-like NK and activated T cells enhances anti-tumor response in gastric cancer.

  2025cites this paper
• Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia

  2025influential citation
• Engineering natural killer cells for cancer immunotherapy

  2025cites this paper
• Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia.

  2025cites this paper
• Prospects and limitations of NK cell adoptive therapy in clinical applications

  2025cites this paper
• A Case Report of Advanced Pulmonary Adenocarcinoma in a Dog Managed with Chemotherapy and Cytokine-Based Immunotherapy

  2025influential citation
• Natural killer cell–based immunotherapy for cancer

  2025cites this paper
• Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy

  2025cites this paper
• Tonic signaling in CAR-T therapy: the lever long enough to move the planet

  2025cites this paper
• Suppressive effects of deep balanced anesthesia on cellular immunity and protein expression: a randomized-controlled pilot study

  2025cites this paper
• What’s in a name? Memory NK cells for cancer immunotherapy

  2025cites this paper
• Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia

  2025cites this paper
• Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications

  2025cites this paper
• Phenotypic, proteomic, and functional analyses of cytokine-induced memory-like NK cells show two distinct subsets based on CD16 expression

  2025influential citation
• Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice

  2025cites this paper
• Anti-retroviral treatment of HIV infected individuals improves the ex vivo generation of memory-like NK cells.

  2025cites this paper
• Chimeric antigen receptor natural killer (CAR-NK) cells: from preclinical promise to clinical reality in cancer immunotherapy

  2025cites this paper
• Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors

  2025cites this paper
• Vaccination of calves with Bacille Calmette Guerin increased the frequency but did not affect aggregation or clustering of natural killer cells in draining lymph nodes

  2025cites this paper
• TIGIT affects CAR NK cell effector function in the solid tumor microenvironment by modulating immune synapse strength.

  2025cites this paper
• Natural killer cell memory: challenges and opportunities for cancer immunotherapy

  2024cites this paper
• Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia

  2024cites this paper
• CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer

  2024cites this paper
• Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation

  2024influential citation
• The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

  2024cites this paper
• Trained immunity inducers in cancer immunotherapy

  2024cites this paper
• Trained immunity: A link between risk factors and cardiovascular disease

  2024cites this paper
• BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors

  2024cites this paper
• Multifunctional bispecific nanovesicles targeting SLAMF7 trigger potent antitumor immunity.

  2024cites this paper
• Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy

  2024cites this paper
• Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation

  2024cites this paper
• Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells

  2024cites this paper
• BCG immunization induced KLRG1+ NK cells show memory-like responses to mycobacterial and HIV antigens

  2024cites this paper
• PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

  2024cites this paper
• Augmentation of NK-cell activity and immunity by combined natural polyphenols and saccharides in vitro and in vivo.

  2024cites this paper
• The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation

  2024cites this paper
• The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma

  2024cites this paper
• Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bhighCD27low memory-like NK cells

  2024cites this paper
• Tissue‐resident memory NK cells: Homing in on local effectors and regulators

  2024cites this paper
• Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.

  2024cites this paper
• The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies

  2024cites this paper
• Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination

  2024cites this paper
• Trained immunity: General and emerging concepts

  2024cites this paper
• Comparative analysis of within-host dynamics of acute infection and viral rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaques

  2024cites this paper
• RORα is required for expansion and memory maintenance of ILC1s via a lymph node-liver axis.

  2024cites this paper
• No time to die: Epigenetic regulation of natural killer cell survival

  2024cites this paper
• NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment

  2024cites this paper
• Reprogramming natural killer cells for cancer therapy.

  2024cites this paper
• CAR-NK cells for cancer immunotherapy: recent advances and future directions

  2024cites this paper
• Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation

  2024cites this paper
• Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.

  2024cites this paper
• Manufacturing CAR-NK against tumors: Who is the ideal supplier?

  2024cites this paper
• Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.

  2024cites this paper
• Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy

  2024cites this paper
• Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response

  2024cites this paper
• Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside

  2024cites this paper
• Elephant in the room: natural killer cells don’t forget HIV either

  2024cites this paper